Mycenax Biotech Inc. (TPEX:4726)
Taiwan · Delayed Price · Currency is TWD 32.45
-0.60 (-1.82%)
Feb 11, 2026, 1:30 PM CST
Mycenax Biotech Market Cap
Mycenax Biotech has a market cap or net worth of 6.85 billion as of February 10, 2026. Its market cap has decreased by -18.77% in one year.
Market Cap
6.85B
Enterprise Value
7.75B
Revenue
649.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
32.45
Market Cap Chart
Since October 31, 2008, Mycenax Biotech's market cap has increased from 584.10M to 6.85B, an increase of 1,072.39%. That is a compound annual growth rate of 15.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 7.09B | 8.23% |
| Dec 31, 2025 | 6.55B | -26.98% |
| Dec 31, 2024 | 8.97B | 22.00% |
| Dec 29, 2023 | 7.35B | -4.53% |
| Dec 30, 2022 | 7.70B | 32.48% |
| Dec 30, 2021 | 5.81B | 40.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gongwin Biopharm Holdings | 9.00B |
| PharmaEngine | 8.98B |
| TaiGen Biopharmaceuticals Holdings | 8.79B |
| Acepodia | 8.09B |
| Adimmune | 7.65B |
| OBI Pharma | 6.33B |
| Savior Lifetec | 6.19B |
| Sinphar Pharmaceutical | 5.82B |